A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of NN1250 [insulin degludec] in Young and Geriatric Subjects With Type 1 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 19 Nov 2009 Actual patient number (27) added as reported by ClinicalTrials.gov.
- 19 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.